The Minnesota CF Center, Department of Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota 55455, USA.
Otolaryngol Head Neck Surg. 2012 Sep;147(3):557-62. doi: 10.1177/0194599812444247. Epub 2012 Apr 18.
Functional endoscopic sinus surgery (FESS) provides symptomatic relief of sinus disease in patients with cystic fibrosis (CF), but it is unclear whether it has beneficial effects on lung disease in this population. This study assessed the effect of FESS on the respiratory status of adult patients with CF.
Retrospective chart review.
Tertiary medical center.
Thirty-two adult patients with CF who underwent 45 operative cases.
Clinical information retrieved for the 12-month periods preceding and following to determine the effect of FESS on the rate of decline in lung function, as well as intravenous antibiotic use and hospitalization for pulmonary exacerbation.
The rate of decline in forced expiratory volume in 1 second and forced vital capacity was not significantly different in the 12 months before and after FESS. Functional endoscopic sinus surgery did not reduce days hospitalized or days on intravenous antibiotics for a respiratory exacerbation in the pre- vs postoperative period. Limiting the analysis to the 30 surgeries that were performed in patients with concomitant respiratory symptoms (ie, excluding the 15 surgeries performed for sinus symptoms alone) did not significantly alter the results. Covariates of importance in CF, including CFTR genotype, gender, or microbiology, did not affect the study results.
These results did not demonstrate an effect of FESS on progression of lung disease in patients with CF, but further research is needed because low statistical power has made some of the negative findings inconclusive.
功能性内窥镜鼻窦手术(FESS)可为囊性纤维化(CF)患者的鼻窦疾病提供症状缓解,但尚不清楚其对该人群的肺部疾病是否具有有益影响。本研究评估了 FESS 对成年 CF 患者呼吸状况的影响。
回顾性图表审查。
三级医疗中心。
32 名接受了 45 例手术的成年 CF 患者。
为确定 FESS 对肺功能下降率、静脉抗生素使用和因肺部恶化而住院的影响,检索了术前和术后 12 个月的临床信息。
FESS 前后 12 个月内,用力呼气量(FEV1)和用力肺活量的下降率没有显著差异。FESS 并未减少呼吸道恶化时的住院天数或静脉使用抗生素的天数。将分析仅限于同时存在呼吸道症状的 30 例手术(即排除仅因鼻窦症状而进行的 15 例手术),也未显著改变结果。CF 的重要协变量,包括 CFTR 基因型、性别或微生物学,并未影响研究结果。
这些结果并未显示 FESS 对 CF 患者肺部疾病进展的影响,但需要进一步研究,因为低统计效力使一些负面发现不确定。